The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move reflecting the accelerating consolidation within the natural ingredients sector, Treatt shareholders have formally approved the acquisition offer from Döhler. The bid was approved at a price of 305 pence per share, marking a critical milestone in the takeover process following the board's earlier recommendation. This approval aims to consolidate the market positions of both entities while providing price certainty for shareholders at the specified offer level.
This acquisition occurs amidst heightened M&A activity in the British ingredients sector, as major players like Döhler seek to bolster their innovation pipelines. Compared to peer transactions, the 305p offer price reflects a premium consistent with current market valuations for specialized ingredient firms per market data. The decision also coincides with a relative improvement in UK consumer sentiment, as the BRC Retail Sales Monitor showed a 3.4% year-on-year increase in June 2026 according to economic calendar data.
Sign in to access this content
Sign InLooking ahead, investors are awaiting the final timeline for the delisting of Treatt shares from the London Stock Exchange following the completion of legal formalities. As the share price stabilizes near the offer level, market attention will shift to upcoming UK economic data, including GDP figures, to assess the macro environment for the merged entity. Traders will also monitor any further management commentary regarding the structural integration plans between Treatt and Döhler.